isocoumarins has been researched along with African Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Stefano, G; Govoni, M; Manerba, M; Vettraino, M | 1 |
| Di Ianni, L; Di Stefano, G; Fiume, L; Manerba, M; Recanatini, M; Roberti, M | 1 |
2 other study(ies) available for isocoumarins and African Lymphoma
| Article | Year |
|---|---|
Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1.
Topics: Adenosine Triphosphate; Burkitt Lymphoma; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Humans; Inhibitory Concentration 50; Isocoumarins; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lactic Acid; NAD; Proto-Oncogene Proteins c-myc; Signal Transduction; Sirtuin 1; Time Factors | 2013 |
Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cell Line, Transformed; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glycolysis; Humans; Isocoumarins; L-Lactate Dehydrogenase; Lymphocytes; Neoplasm Proteins; Organic Chemicals; Osmolar Concentration; Reactive Oxygen Species | 2015 |